Yahoo Finance - WJSAM Finance Hub

Yahoo Finance

Vitalik Buterin: Hedging on Prediction Markets Could 'Replace Fiat Currency'

Vitalik Buterin: Hedging on Prediction Markets Cou...

1 month ago 27

Up 50% in One Year: Why a Fund Cut $5 Million in TriMas Stock but Held Onto a 3% Position

Up 50% in One Year: Why a Fund Cut $5 Million in T...

1 month ago 22

Metaplanet Posts $605 Million Loss After Spending Billions on Bitcoin

Metaplanet Posts $605 Million Loss After Spending ...

1 month ago 20

Intel Stock Has Gotten Way Ahead of Lip-Bu Tan's Turnaround Plans. Will Investors Regret Buying?

Intel Stock Has Gotten Way Ahead of Lip-Bu Tan's T...

1 month ago 17

Real Estate Rebound? The 3X Play for Investors Betting on a Commercial Property Pivot

Real Estate Rebound? The 3X Play for Investors Bet...

1 month ago 15

What Makes BioMarin (BMRN) so Attractive

What Makes BioMarin (BMRN) so Attractive

1 month ago 20

Summit Therapeutics (SMMT) Grabs Investor Attention After Major FDA Breakthrough

Summit Therapeutics (SMMT) Grabs Investor Attentio...

1 month ago 18

FDA Guidance on MRD Negativity Bodes Well for Legend Biotech (LEGN)

FDA Guidance on MRD Negativity Bodes Well for Lege...

1 month ago 19

Soleno Therapeutics (SLNO) Sparks Confidence Amid Topline Outperformance

Soleno Therapeutics (SLNO) Sparks Confidence Amid ...

1 month ago 17

FDA-Issued CRL for Relacorilant NDA Leads to Bullish Views Around Corcept Therapeutics (CORT)

FDA-Issued CRL for Relacorilant NDA Leads to Bulli...

1 month ago 14

Strong Rare Disease Pipeline Drives Favorable Sentiment for Ultragenyx (RARE)

Strong Rare Disease Pipeline Drives Favorable Sent...

1 month ago 17

Wave Life Sciences (WVE) to Benefit From Optimism Surrounding Alpha-1 Antitrypsin Deficiency Program

Wave Life Sciences (WVE) to Benefit From Optimism ...

1 month ago 17

Dyne Therapeutics (DYN) Attains Orphan Drug Designation From Japanese Ministry

Dyne Therapeutics (DYN) Attains Orphan Drug Design...

1 month ago 15

Impressive Clinical Pipeline Leads to Bullish Sentiment for Vaxcyte (PCVX)

Impressive Clinical Pipeline Leads to Bullish Sent...

1 month ago 16

Stifel Initiates Coverage on Olema Pharmaceuticals (OLMA) With Buy Rating

Stifel Initiates Coverage on Olema Pharmaceuticals...

1 month ago 14

Here is Why Beam Therapeutics (BEAM) Appears so Attractive

Here is Why Beam Therapeutics (BEAM) Appears so At...

1 month ago 20

Guggenheim Raises Price Target for Praxis Precision Medicines (PRAX)

Guggenheim Raises Price Target for Praxis Precisio...

1 month ago 15

Orexin-2 Receptor Data Reinforces a Positive Outlook for Centessa (CNTA)

Orexin-2 Receptor Data Reinforces a Positive Outlo...

1 month ago 20